Ideagen Signs Deal with Leading Cancer Treatment Company
Leading global provider of software products to companies operating in highly regulated industries, Ideagen Plc, has announced a new customer for Qualsys, the eQMS product which is now part of the Q-Pulse suite of products.Blaze Bioscience, The Tumor Paint Company®, formed in 2010 in Seattle, is a privately held biotechnology company that is developing leading edge products for the treatment of cancer. The company’s co-founder, Dr Jim Olson, a paediatric neuro-oncologist at Fred Hutchinson Cancer Research Centre and Seattle Children’s Hospital, is an inventor and pioneer of a revolutionary